Nature Communications (Oct 2021)

Clonal hematopoiesis is associated with risk of severe Covid-19

  • Kelly L. Bolton,
  • Youngil Koh,
  • Michael B. Foote,
  • Hogune Im,
  • Justin Jee,
  • Choong Hyun Sun,
  • Anton Safonov,
  • Ryan Ptashkin,
  • Joon Ho Moon,
  • Ji Yeon Lee,
  • Jongtak Jung,
  • Chang Kyung Kang,
  • Kyoung-Ho Song,
  • Pyoeng Gyun Choe,
  • Wan Beom Park,
  • Hong Bin Kim,
  • Myoung-don Oh,
  • Han Song,
  • Sugyeong Kim,
  • Minal Patel,
  • Andriy Derkach,
  • Erika Gedvilaite,
  • Kaitlyn A. Tkachuk,
  • Brian J. Wiley,
  • Ireaneus C. Chan,
  • Lior Z. Braunstein,
  • Teng Gao,
  • Elli Papaemmanuil,
  • N. Esther Babady,
  • Melissa S. Pessin,
  • Mini Kamboj,
  • Luis A. Diaz,
  • Marc Ladanyi,
  • Michael J. Rauh,
  • Pradeep Natarajan,
  • Mitchell J. Machiela,
  • Philip Awadalla,
  • Vijai Joseph,
  • Kenneth Offit,
  • Larry Norton,
  • Michael F. Berger,
  • Ross L. Levine,
  • Eu Suk Kim,
  • Nam Joong Kim,
  • Ahmet Zehir

DOI
https://doi.org/10.1038/s41467-021-26138-6
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 8

Abstract

Read online

Clonal haematopoiesis (CH) has been associated with altered inflammatory profiles and increased risk of cardiovascular and malignant diseases. Here, the authors analyze patient data from two different cohorts and show that CH is associated with severe infections and severe Covid19.